Studies showed that the assay demonstrated a 94.90% sensitivity in polymerase chain reaction-confirmed positive samples.

Specialists discuss diagnostic technologies, treatment strategies, and research that are improving outcomes for young ...

The Elecsys pTau181 test is the second blood test cleared by the FDA this year for use in Alzheimer’s evaluation. In May, the agency approved Fujirebio’s Lumipulse test, which detects a different set ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to Augurex Life Sciences’ SPINEstat ...

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in ...

A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology ...

The US Food and Drug Administration’s (FDA) recent clearance of Roche’s blood-based Alzheimer’s disease test will boost ...

What strategic role will the new Radiology R&D Hub in Bangalore play in Bayer’s global innovation roadmap for radiology? The Bengaluru R&D India Hub is a significant addition to Bayer’s […] ...

AI algorithm has achieved remarkable accuracy in detecting cardiac amyloidosis, outperforming traditional diagnostic methods.

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially ...

Through robust use of telehealth, Catalight offers care to 99% of families within 10 days – roughly 80% faster than national ...

Manufacturing better batteries, faster electronics, and more effective pharmaceuticals depends on the discovery of new ...